Arynta 24338-0103
Generic: Lisdexamfetamine Dimesylate Oral
Product NDC
24338-0103- Manufacturer
- Azurity Pharmaceuticals, Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- March 20, 2026
- Listing Expires
- December 31, 2027
- Application
- NDA219847
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 10 mg/mL |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
1 BOTTLE in 1 CARTON (24338-103-01) / 30 mL in 1 BOTTLE